ISPOR 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Exhibitor Directory
Media Partners
Photo Gallery
ISPOR
2024
May 5-8, 2024
Home
Events
Past Conferences
ISPOR 2024
Program
Plenary Sessions
Session
Budget Impact Analysis of Zanubrutinib + Obinutuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma in the United States
May 6, 2024, 16:30 PM
«
1301
1302
1303
1304
1305
1306
1307
(current)
1308
1309
1310
»